Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours

BACKGROUND: In recent years, targeted therapy has received widespread attention. Among these therapies, anti-angiogenic targeted drugs have become one of the hotspots of research. Apatinib is a novel oral small molecule anti-angiogenic agent that has been clinically tested in a variety of solid tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guohui, Wang, Chunbo, He, Yunlong, E, Mingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819520/
https://www.ncbi.nlm.nih.gov/pubmed/31661009
http://dx.doi.org/10.1186/s40360-019-0362-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819520/
https://www.ncbi.nlm.nih.gov/pubmed/31661009
http://dx.doi.org/10.1186/s40360-019-0362-2

Ejemplares similares